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Abstract
Background: Cell-mediated immunity is critical for clearance of central nervous system (CNS) infection with the
encephalitic flavivirus, West Nile virus (WNV). Prior studies from our laboratory have shown that WNV-infected
neurons express chemoattractants that mediate recruitment of antiviral leukocytes into the CNS. Although the
chemokine receptor, CCR5, has been shown to play an important role in CNS host defense during WNV infection,
regional effects of its activity within the infected brain have not been defined.
Methods: We used CCR5-deficient mice and an established murine model of WNV encephalitis to determine
whether CCR5 activity impacts on WNV levels within the CNS in a region-specific fashion. Statistical comparisons
between groups were made with one- or two-way analysis of variance; Bonferroni’s post hoc test was subsequently
used to compare individual means. Survival was analyzed by the log-rank test. Analyses were conducted using Prism
software (GraphPad Prism). All data were expressed as means ± SEM. Differences were considered significant if P ≤ 0.05.
Results: As previously shown, lack of CCR5 activity led to increased symptomatic disease and mortality in mice
after subcutaneous infection with WNV. Evaluation of viral burden in the footpad, draining lymph nodes, spleen,
olfactory bulb, and cerebellum derived from WNV-infected wild-type, and CCR5−/− mice showed no differences
between the genotypes. In contrast, WNV-infected, CCR5−/− mice exhibited significantly increased viral burden in
cortical tissues, including the hippocampus, at day 8 post-infection. CNS regional studies of chemokine expression via
luminex analysis revealed significantly increased expression of CCR5 ligands, CCL4 and CCL5, within the cortices of
WNV-infected, CCR5−/− mice compared with those of similarly infected WT animals. Cortical elevations in viral
loads and CCR5 ligands in WNV-infected, CCR5−/− mice, however, were associated with decreased numbers of
infiltrating mononuclear cells and increased permeability of the blood-brain barrier.
Conclusions: These data indicate that regional differences in chemokine expression occur in response to WNV
infection of the CNS, and that cortical neurons require CCR5 activity to limit viral burden in this brain region.
Keywords: CCR5, Viral encephalitis, Blood-brain barrier, Cerebral cortex, T cell, Macrophage

Background
Infection with the encephalitic flavivirus, West Nile virus
(WNV), is the leading cause of domestically acquired
arboviral disease in the USA [1]. Acute infectious syndromes after infection with WNV include a self-limited
febrile illness, West Nile fever (WNF), or more severe
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neuroinvasive diseases (WNND), including meningitis, encephalitis, or flaccid paralysis. The entry of virus-specific
T cells into the CNS parenchyma is essential for viral
clearance and survival in both human and murine subjects
with WNV encephalitis [2–6]. Indeed, the increased incidence of WNV neuroinvasive disease in patients on
anti-T cell therapies [5, 7] and in mice with T cell deficiencies [4, 8–10] indicates that the clearance of WNV
within the CNS relies heavily on cell-mediated immune
responses that promote the CNS entry and effector functions of CD8+ T cells [11, 12]. While studies indicate that
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CNS regions differ in the extent of inflammatory infiltrates
during viral encephalitis [13–16], regional differences in
expression of guidance cues that promote T cell entry have
not been established. These guidance cues, combined with
the tightly controlled egress of leukocytes from the perivascular sites, coordinate the migration of leukocyte subsets for protective and pathologic purposes.
In most tissues, leukocyte recruitment is orchestrated by
a series of coordinated leukocyte-endothelial interactions
involving several families of molecular regulators including
selectins, integrins, and chemokines [17, 18]. Chemokines
are a superfamily of over 50 structurally homologous
chemotactic, heparin binding, secreted proteins with their
target cell specificity conferred by pertussis toxin (PTX)
sensitive, Gαi-coupled seven transmembrane glycoprotein chemokine receptors. Of interest, CXCL12 and its
receptors are believed to most resemble the ancestral
chemokine-receptor pair [19] suggesting that CXC chemokines are evolutionarily older than CC chemokines. In
published studies, we have determined that upregulation
of proinflammatory chemokines during WNV encephalitis
may occur in a region-specific fashion [2, 20]. For example, cerebellar expression of CXCL10 is required for
viral clearance of this brain region by CXCR3-expressing,
virus-specific CD8+ T cells [20]. Differences in regional
chemokine expression may thus determine the spatial patterns of leukocyte trafficking, leading to variability in viral
clearance and immunopathology between CNS regions.
CCL3–5, chemokines that all bind the chemokine receptor CCR5, are strongly induced in the CNS after WNV
infection [2, 21–23]. Monocytes, NK and T cells express
CCR5 and targeted deletion of CCR5 in B6129PF2 mice is
associated with depressed leukocyte trafficking, increased
viral burden and enhanced mortality [21]. Similarly,
homozygosity for CCR5Δ32, a nonfunctional variant of
chemokine receptor CCR5, is markedly increased among
symptomatic WNV-seropositive patients [22, 24]. In
the current study, we examined the role of CCR5 in
C57BL/6 mice during WNV infection, focusing on CNS
region-specific effects. We found that CCR5 is required
for virologic control specifically within the CNS cortex.
This finding was associated with a significant decrease in
immune cell infiltrates, increased blood-brain barrier (BBB)
permeability, and elevated levels of CCR5 ligands in WNVinfected CCR5−/− compared with WT mice. These data
suggest that increased viral replication within the CNS
modulates BBB function and support the notion that nonredundancy in chemokine-mediated inflammation among
CNS regions may be due to evolutionary mechanisms.
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mice were also commercially obtained (Jackson Laboratories, stock number 005427) and bred in the animal facilities at the Washington University School of Medicine. All
animals were housed under pathogen-free conditions in
the animal facilities of the Washington University School
of Medicine. All experiments were performed in compliance with Washington University animal studies guidelines and comply with “Animal Research: Reporting In
Vivo Experiments (ARRIVE) guidelines.” Mice were inoculated subcutaneously via footpad injection (50 μl)
with 100 PFU of WNV as previously described [25].
WNV strain 3000.0259 was isolated in New York in
2000 [26] and passaged once in C6/36 cells. Viral titers
were measured by plaque assay on BHK21-15 cells as
previously described [27]. Cortical, cerebellar, and brainstem regions of the CNS were dissected based on visual
information, such as differences in color of adjacent tissues, and on the natural anatomical boundaries of certain regions present in the brain. Clinical disease was
monitored and scored as previously described [28]. The
designation for the clinical scores is as follows: 1 ruffled
fur/hunched, 2 paresis/difficulty walking, 3 paralysis, 4
moribund, and 5 dead.
BBB permeability assay

At day 5 and 8 after WNV infection, mice were injected
intraperitoneally (IP) with sodium fluorescein dye
(100 mg/ml) as previously described [29]. After 45 min,
mice were perfused, serum was collected, and CNS tissues
were harvested. Both the serum and tissue homogenates
were incubated overnight at 4 °C in 2 % trichloroacetic
acid at 1:1 dilution to precipitate protein and then the supernatants were neutralized in equal volumes of borate
buffer. Fluorescence emission at 538 nm was determined
using a microplate reader Synergy™ H1 and Gen5™ software (BioTek Instruments, Inc.). Fluorescence concentration was calculated from a standard curve, and tissue
fluorescence values were normalized to serum fluorescence values from identical mice.
Chemokine analysis

The chemokine Bio-Plex assay was performed on tissue
samples from mice at day 8 after infection from WNVinfected mice. Tissue was homogenized following extensive cardiac perfusion with PBS and was analyzed
using a 6-plex Luminex assay (Millipore) followed by
analysis on a Bio-Plex 200 (Bio-Rad). Concentrations of
chemokines were normalized to total protein levels.
Leukocyte isolation

Methods
Murine model of WNV encephalitis

Eight-week-old C57BL/6 wild-type mice were obtained
commercially (Jackson Laboratories). Congenic ccr5−/−

Cells were isolated from the CNS of WT and CCR5−/−
mice at day 6 and 8 after WNV infection. Following cell
count and viability analysis, cells were stained with fluorescently conjugated antibodies to CD4, CD8β, CD11b,
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and CD45 as previously described [30]. Samples were
analyzed following staining using a LSRII flow cytometer
(Beckton Dickinson) to collect up to 30,000 events in a
broad gate defined by forward- and side-scatter attributes. The absolute count of respective leukocyte subsets was calculated based on the percent positive cells
from data analysis, which was performed using FlowJo
software (Tree Star).
Immunohistochemistry

Brain tissues were perfused with 4 % paraformaldehyde
and isolated for frozen sections. Tissue sections were
permeabilized and blocked in 0.1 % Triton X-100 and
10 % goat serum, followed by incubation with primary
antibodies CD-3 1:200 (Dako) and WNV antigen 1:100
(Diamond lab) or CD-3 1:200 (Dako), CD31 1:20 (BD)
and endomucin 1:200 (eBioscience/Affymetrix) overnight at 4 °C. Primary antibodies were detected with
goat anti-rabbit Alexa Fluor 488 (CD3), goat anti-rat
Alexa Fluor 555 (WNV antigen) and goat anti-rat Alexa
Fluor 555 (CD31, endomucin) followed by nuclear DAPI
counterstaining. Tissues were then washed and examined by confocal microscopy.
Statistical analysis

Statistical comparisons between groups were made with
one- or two-way analysis of variance; Bonferroni’s post
hoc test was subsequently used to compare individual
means. Survival was analyzed by the log-rank test. Analyses were conducted using Prism software (GraphPad
Prism). All data were expressed as means ± SEM. Differences were considered significant if P ≤ 0.05.

Results
CCR5-deficient mice exhibit higher cortical viral loads
with increased BBB permeability

In prior studies, mice with targeted deletion of CCR5
(B6129PF2 background) exhibited 100 % lethality after subcutaneous inoculation with WNV-NY (strain NY9935262;
104 ffu), which was attributed to the decreased CNS entry
of all leukocyte subpopulations including macrophages,
T and NK cells [21]. In this study, mortality due to
WNV infection was not significantly enhanced by increases in WNV inoculum beyond 102 focus-forming
units. To determine whether CCR5-deficient animals
(C57BL/6 background) exhibited similar survival effects,
8-week-old, C57BL/6 wild-type (WT), and CCR5-deficient
mice were infected subcutaneously via footpad inoculation
with 102 plaque-forming units (PFU) of strain WNVNY99 and followed for severity of disease and survival.
WNV-infected CCR5−/− mice exhibited enhanced mortality (Fig. 1a, WT 20 %; CCR5−/− 50 %) and significantly
higher clinical disease severity scores (Fig. 1b, c), compared with similarly infected WT animals. Analysis of viral
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loads in the footpad and peripheral organs did not reveal differences between the two genotypes at any time
points after WNV infection (Fig. 2a). In contrast, analyses of CNS tissues detected significantly higher viral
loads in the cortices, but not within the brainstem or
cerebella, of WNV-infected CCR5−/− compared with
WT mice (Fig. 2b). Of note, because of the difference
in survival observed between genotypes, the CCR5deficient mice assessed at day 10 do not include those
that have succumbed to viral encephalitis and will naturally include those with lower viral titers that do survive.
WT animals exhibit more survival and generally exhibit
peak viral loads at days 8–10, which undergo clearance
thereafter [3, 12], leading to similar viral loads at this later
time point. These data suggest that CCR5 is critical for virologic control specifically within the cortex during WNV
encephalitis.
In recently published studies, we demonstrated that
detection of WNV by host tissues induces local innate
immune cytokine expression by CNS endothelium,
regulating BBB structure and function [29]. Given the
increased viral load in the cortices of CCR5−/− mice
compared with similarly infected WT, we performed
fluorometric assessment of BBB permeability following
the intraperitoneal (IP) administration of sodium fluorescein. Cerebellar and brainstem tissues derived from
WNV-infected WT and CCR5−/− mice exhibited similar
increases in extravasation of sodium fluorescein at 5
and 8 days post-infection (Fig. 3). However, similar analyses of cortical tissues revealed a significant increase in
BBB permeability at 8 days post-infection in CCR5−/−
mice compared with WT controls (Fig. 3). These findings are consistent with previous data linking higher
viral loads with worsened BBB stability [31, 32].
CCR5-deficient mice exhibit increased chemokines within
the cortex with less inflammation

In prior studies, elevated viral loads within the CNS of
WNV-infected mice were also linked to increased expression of chemoattractant cytokines [2, 33]. Consistent
with this, at time points when viral loads in the cortices
of WNV-infected CCR5−/− mice are highest, levels of
CCR5 ligands, CCL3 and CCL5, were significantly elevated compared with cortical tissues of similarly infected
WT mice (Fig. 4a). Moreover, there were no differences
between the genotypes in chemokine expression levels
in the cerebella of WNV-infected mice (Fig. 4b). Given
the increase in CCR5 chemoattractants and increased
BBB permeability, we wondered whether WNV-infected
CCR5 mice would exhibit increased parenchymal entry
of mononuclear cells. To address this, we performed
flow cytometric analyses of infiltrating mononuclear cells
within the cortices and cerebella of WNV-infected WT
versus CCR5−/− mice on days 5, 8, and 10 post-infection.
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Fig. 1 CCR5 is necessary to reduce WNV-associated disease and mortality. WT and CCR5−/− mice were infected with 102 PFU of WNV via the
subcutaneous route. a Survival was monitored for 28 days after infection. n = 30 mice, *P = 0.0503 (log-rank test). b Clinical scores were monitored daily
for 12 days after infection. The designation for the clinical scores is as follows: 1 ruffled fur/hunched; 2 altered gait, slow movement; 3 not moving but
responsive; 4 moribund; and 5 death. c Individual clinical scores are shown at each time point for WT (left) and CCR5−/− (right) mice. Asterisks indicate
values that are statistically significant (**P < 0.005, ***P < 0.001)

Inflammatory infiltrates, CD45hi leukocytes, within the
cerebella of WNV-infected WT and CCR5-deficient
mice peaked at day 8 post-infection and exhibited similar total numbers of CD45lo and CD45hi mononuclear
cells (Fig. 5a). In contrast, total numbers of infiltrating
CD45hi leukocytes were significantly higher in cortical
tissues of WNV-infected WT mice, compared with their
CCR5−/− counterparts, on day 8 post-infection (Fig. 5c).
Although similar numbers of CD45hi infiltrating leukocytes, comprised of CD4+ and CD8+ (lymphocytes) and
CD11b+ (macrophages) were present between WT and

CCR5−/− mice in the cerebellar tissues on day 8 following
WNV infection (Fig. 5b), the total number of CD45hi CD4
+
and CD8+ lymphocytes was significantly decreased in the
cortices of CCR5-deficient, WNV-infected mice on day 8
post-infection (Fig. 5d). CD45hi CD11b+ leukocytes (macrophages) were decreased in both genotypes on 10 postinfection (Fig. 5d). Immunohistochemical analyses of T cell
infiltration within the cortices of WNV-infected, WT and
CCR5−/− mice at day 8 post-infection revealed T cell infiltration with little WNV antigen in WT hosts. In contrast,
low numbers of parenchymal T cells were detected within

Fig. 2 CCR5 restricts WNV replication in cortical tissues of the CNS. WT and CCR5−/− mice were infected via footpad with 102 PFU of WNV.
a Viral burden within the footpad, draining lymph node (popliteal LN), and spleen of WT and CCR5−/− mice were measured at indicated days
post-infection. b WNV levels within the cortex, cerebellum, and brainstem were measured at days 6, 8, and 10 post-infection. Tissue homogenates were
analyzed for viral burden by infectious plaque assay. Data are shown as the mean PFU per gram of tissue from 6 to 10 mice per time point. Dotted lines
denote the limit of detection of the respective assays. Asterisks indicate values that are statistically significant (*P < 0.05)
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Fig. 3 BBB permeability increases within the cortices of the WNV-infected CCR5−/− CNS. a Following inoculation with 102 PFU of WNV in the footpad,
WT and CCR5−/− mice were assessed for BBB sodium fluorescein permeability in different CNS regions on the indicated days post-infection.
BBB permeability was determined by the accumulation of sodium fluorescent dye in CNS tissues after intraperitoneal administration. Data are
shown as mean fluorescence normalized to the mean value for uninfected animals ± SEM for four mice per time point and are representative
of two independent experiments. Asterisks indicate values that are statistically significant (*P < 0.05)

CCR5-deficient hosts, despite increased detection of WNV
antigen compared with WT animals (Fig. 5e). Moreover,
vessel-associated T cells were increased in CCR5−/− mice,
while parenchymal T cells predominated in WT animals
(5F). Taken altogether, these data indicate that CCR5 is
not required for antiviral, cell-mediated immunity in the
periphery. In the CNS, however, CCR5 is required for the
entry of leukocytes specifically into cortex.

Discussion
While CCR5 has been shown to be critical for survival
of WNV-infected mice, region-specific roles for this receptor within the CNS has not been previously described. Here, we demonstrate that targeted deletion of
CCR5 leads to loss of virologic control specifically within
cortical tissues of the CNS, which also exhibit enhanced
BBB permeability and elevated levels of CCR5 ligands,
CCL3 and CCL5. Despite these latter findings, WNVinfected CCR5−/− mice showed decreased infiltration of
all mononuclear cells into cortical regions compared

with similarly infected WT animals. These data suggest
region-specific roles for CCR5 ligands within the virally
infected CNS.
Although mortality of WNV-infected, CCR5−/− mice
were only moderately increased, symptomatic disease was
significantly enhanced. This is reminiscent of findings in
patients with the Δ32CCR5 mutation, which exhibit increase in symptomatic diseases after WNV infection, but
no increase in mortality [22, 34]. In previous studies using
CCR5−/− mice on a B6129PF2 background, infection with
WNV-NY99 led to uniform mortality. The severe phenotype observed in CCR5-deficient mice may be due to
strain related variations in inflammatory responses between C57BL/6 versus mixed background (B6129PF2)
strains [35].
Increased symptoms of encephalitis in CCR5-deficient
mice in our study were associated with increased cortical
viral loads. This region-specific effect is consistent with
the other reports of regional differences in expression of
inflammatory molecules during viral infections of the

Fig. 4 CCR5 ligands are increased within the cortical region of the CCR5−/− CNS during WNV infection. Expression of chemotactic cytokines was
measured in the (a) cortical and (b) cerebellar regions of the CNS harvested from WNV-infected WT and CCR5−/− mice at day 8 post-infection by
Bio-Plex assay. Results represent means ± SEM of five mice per group. Asterisks indicate values that are statistically significant (***P < 0.001)
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Fig. 5 CCR5 is necessary for recruitment of mononuclear cells to the cortical region of the WNV-infected CNS. The immunophenotype of brain
leukocytes and their locations within the cortex were determined in WNV-infected WT and CCR5−/− mice. Mice were infected with 102 PFU of
WNV in the footpad. The cerebellum (a, b) and cortex (c, d) were harvested and analyzed by flow cytometry at the indicated days after infection.
In separate infections, cortical tissues from WNV-infected WT and CCR5−/− mice were examined for locations of CD3+ cells with respect to
WNV antigen or the vasculature at day 8 post infection. a, c The numbers of CD45lo and CD45hi leukocyte populations were determined at
the indicated time points after infection. b, d The numbers of CD4+, CD8+, and CD11b+ (macrophage) populations from the CD45hi leukocyte
population were determined at the indicated time points after infection. Results represent the means ± SEM of at least four mice per group.
Asterisks indicate values that are statistically significant (*P < 0.05, **P < 0.01). e Detection of WNV antigen (red) and CD3+ T cells (green). Nuclei
were counterstained (blue). f Detection of CD31+ endothelial cells (red) and CD3+ T cells (green). Images are representative of 10 images per
mouse for 3 mice/genotype. In all images, arrows indicate CD3+ cells. Scale bar = 25 μm

CNS [33, 36]. The lack of effect of CCR5-deficiency on
viral loads in the periphery or in other CNS regions suggests that CCR5+ antiviral lymphocytes are specifically
required for virologic control within the cortex. Of note,
adoptive transfer of CCR5-sufficient cells into WNVinfected, CCR5-deficient mice were previously shown to
control viral replication and improve survival [21], which
may have been due to improved virologic control in the
forebrain. This is similar to the findings regarding the role
of CXCR3, which is dispensable for the control of viral infection in the periphery and in most CNS compartments
but required for CD8 T cell-mediated antiviral responses

specifically within the cerebellum. That evolutionary older
CXC chemokines would be important for virologic control in the hindbrain while CC chemokines, which evolved
with adaptive immunity, would play a bigger antiviral role
in the forebrain is quite accordant [19, 37, 38]. Recent
studies also indicate that activated microglia in the setting
of WNV encephalitis express proinflammatory cytokines
and chemokines [39]. Further studies evaluating regional
differences in chemoattractant responses of various neural
cell types during viral infections should yield important insights regarding how viruses differentially impact CNS
antiviral responses.
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We previously showed that clearance of virus is associated with prompt resolution of encephalitis, with decreased
numbers of infiltrating T cells [40]. Consistent with this,
WT mice exhibited increased parenchymal T cells and low
levels of WNV antigen at day 8 post-infection followed by
decreased numbers of CNS-infiltrated leukocytes at day 10
post-infection. CNS infiltrating T cells and macrophages
express cytokines, such as interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-1β, may induce disruption of interendothelial cell tight junctions
(TJs) via activation of the GTPase RhoA [11, 29]. The
resulting increase in BBB permeability is associated
with the migration of mononuclear cells into the CNS
parenchyma, with enhanced viral clearance [40]. In our
study, despite the increase in BBB permeability observed in cortical tissues of WNV-infected, CCR5−/−
mice, significantly fewer leukocytes trafficked into this
CNS region. The increase in BBB permeability in the
setting of high MOIs of WNV is likely due to effects of
inflammasome activation, which disrupts tight junction
integrity via effects of IL-1β [29]. In addition, high
MOIs of WNV which induce necrotic cell death and
cause cells to release immunogenic factors as they die
including inflammatory cytokines like HMGB1, while
low MOIs induce apoptosis, which is typically nonimmunogenic [41]. This is consistent with prior studies
showing that pattern recognition receptor activation in
the presence of WNV in the BBB endothelium results in
cytokine-dependent modulation of Rho GTPase signaling,
exerting regulatory control over BBB permeability and TJ
integrity [29]. Thus, it is possible that the high viral loads
within the cortices of WNV-infected, CCR5−/− mice induce viral sensing mechanisms, such as activation of Tolllike receptor 3 [29, 42], that promote loss of BBB integrity.

Conclusions
In conclusion, our data identify CCR5 as critically important for cell-mediated immunity during cortical infections
with neurotropic virus. Loss of CCR5 results in decreased
ability to recruit antiviral mononuclear cells specifically
into WNV-infected, cortical tissues, which are essential
for virologic control. The data also raise new questions regarding the effects of high CNS viral loads on BBB permeability and the differential expression of chemokines
within brain regions during viral infections of the CNS.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DMD participated in the design and interpretation of experiments, wrote
the manuscript, and generated all figures; BPD performed experiments
evaluation blood-brain barrier (BBB) function, TJP participated in the design
and interpretation of experiments and performed all non-BBB experiments.
RSK conceived of the study and participated in its design and coordination,
and helped to draft the manuscript. All authors read and approved the
final manuscript.

Page 7 of 8

Acknowledgements
This study was supported by the National Institutes of Health/National
Institute of Neurological Disorders and Stroke Grant R01NS052632 and
National Institute of Allergy and Infectious Diseases Grant U19 AI083019
(both to R.S.K). B.P.D. was supported by NSF (DGE-1143954) and NIH
(F31-NS07866-01) Fellowships.
Author details
1
Department of Medicine, Washington University School of Medicine, St
Louis, MO 63110, USA. 2Department of Pathology & Immunology,
Washington University School of Medicine, St Louis, MO 63110, USA.
3
Department of Anatomy & Neurobiology, Washington University School of
Medicine, St Louis, MO 63110, USA.
Received: 18 June 2015 Accepted: 25 November 2015

References
1. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res.
2010;85:328–45.
2. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, et al. Neuronal
CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus
encephalitis. J Virol. 2005;79:11457–66.
3. Shrestha B, Diamond MS. Role of CD8+ T cells in control of West Nile virus
infection. J Virol. 2004;78:8312–21.
4. Wang Y, Lobigs M, Lee E, Mullbacher A. CD8+ T cells mediate recovery and
immunopathology in West Nile virus encephalitis. J Virol. 2003;77:13323–34.
5. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, Laird SP, McNutt JT, Escott
EJ, et al. Naturally acquired West Nile virus encephalomyelitis in transplant
recipients: clinical, laboratory, diagnostic, and neuropathological features.
Arch Neurol. 2004;61:1210–20.
6. Cushing MM, Brat DJ, Mosunjac MI, Hennigar RA, Jernigan DB, Lanciotti R, et
al. Fatal West Nile virus encephalitis in a renal transplant recipient.
Am J Clin Pathol. 2004;121:26–31.
7. Katz LM, Bianco C. West Nile virus. N Engl J Med. 2003;349:1873–4. author
reply 1873-1874.
8. Wang T, Gao Y, Scully E, Davis CT, Anderson JF, Welte T, et al. Gamma delta
T cells facilitate adaptive immunity against West Nile virus infection in mice.
J Immunol. 2006;177:1825–32.
9. Wang T, Scully E, Yin Z, Kim JH, Wang S, Yan J, et al. IFN-gamma-producing
gamma delta T cells help control murine West Nile virus infection.
J Immunol. 2003;171:2524–31.
10. Wang Y, Lobigs M, Lee E, Koskinen A, Mullbacher A. CD8(+) T cell-mediated
immune responses in West Nile virus (Sarafend strain) encephalitis are
independent of gamma interferon. J Gen Virol. 2006;87:3599–609.
11. Durrant DM, Daniels BP, Klein RS. IL-1R1 signaling regulates CXCL12-mediated
T cell localization and fate within the central nervous system during West Nile
virus encephalitis. J Immunol. 2014;193:4095–106.
12. Durrant DM, Robinette ML, Klein RS. IL-1R1 is required for dendritic cellmediated T cell reactivation within the CNS during West Nile virus encephalitis.
J Exp Med. 2013;210:503–16.
13. Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection: MR imaging
findings in the nervous system. AJNR Am J Neuroradiol. 2005;26:289–97.
14. Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx. 2005;
2:324–32.
15. Tien RD, Felsberg GJ, Osumi AK. Herpesvirus infections of the CNS: MR
findings. AJR Am J Roentgenol. 1993;161:167–76.
16. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al.
Viral encephalitis: a review of diagnostic methods and guidelines for
management. Eur J Neurol. 2005;12:331–43.
17. Kim CH. Chemokine-chemokine receptor network in immune cell trafficking.
Curr Drug Targets Immune Endocr Metabol Disord. 2004;4:343–61.
18. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte
trafficking and regional immunity. Adv Immunol. 1999;72:209–53.
19. Huising MO, Stet RJ, Kruiswijk CP, Savelkoul HF, Lidy Verburg-van Kemenade
BM. Molecular evolution of CXC chemokines: extant CXC chemokines
originate from the CNS. Trends Immunol. 2003;24:307–13.
20. Zhang B, Chan YK, Lu B, Diamond MS, Klein RS. CXCR3 mediates regionspecific antiviral T cell trafficking within the central nervous system during
West Nile virus encephalitis. J Immunol. 2008;180:2641–9.

Durrant et al. Journal of Neuroinflammation (2015) 12:233

21. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine
receptor CCR5 promotes leukocyte trafficking to the brain and survival in
West Nile virus infection. J Exp Med. 2005;202:1087–98.
22. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, et al. CCR5
deficiency increases risk of symptomatic West Nile virus infection.
J Exp Med. 2006;203:35–40.
23. Shirato K, Kimura T, Mizutani T, Kariwa H, Takashima I. Different chemokine
expression in lethal and non-lethal murine West Nile virus infection.
J Med Virol. 2004;74:507–13.
24. Lim JK, Louie CY, Glaser C, Jean C, Johnson B, Johnson H, et al. Genetic
deficiency of chemokine receptor CCR5 is a strong risk factor for
symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the
US epidemic. J Infect Dis. 2008;197:262–5.
25. Engle MJ, Diamond MS. Antibody prophylaxis and therapy against West Nile
virus infection in wild-type and immunodeficient mice. J Virol. 2003;77:12941–9.
26. Ebel GD, Dupuis 2nd AP, Ngo K, Nicholas D, Kauffman E, Jones SA, et al.
Partial genetic characterization of West Nile virus strains, New York State,
2000. Emerg Infect Dis. 2001;7:650–3.
27. Brien JD, Lazear HM, Diamond MS. Propagation, quantification, detection, and
storage of West Nile virus. Curr Protoc Microbiol. 2013;31:15D 13 11-15D 13 18.
28. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, et al.
Tregs control the development of symptomatic West Nile virus infection in
humans and mice. J Clin Invest. 2009;119:3266–77.
29. Daniels BP, Holman DW, Cruz-Orengo L, Jujjavarapu H, Durrant DM, Klein RS.
Viral pathogen-associated molecular patterns regulate blood-brain barrier
integrity via competing innate cytokine signals. mBio. 2014;5:e01476.
30. McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS. CXCL12 limits
inflammation by localizing mononuclear infiltrates to the perivascular
space during experimental autoimmune encephalomyelitis. J Immunol.
2006;177:8053–64.
31. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, Verma S. West Nile virusinduced disruption of the blood-brain barrier in mice is characterized by
the degradation of the junctional complex proteins and increase in multiple
matrix metalloproteinases. J Gen Virol. 2012;93:1193–203.
32. Wang P, Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, et al. Matrix
metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol.
2008;82:8978–85.
33. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, et al. CCR5
deficiency increases risk of symptomatic West Nile virus infection. J Exp
Med. 2006;203(1):35-40.
34. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, et al.
CCR5 deficiency is a risk factor for early clinical manifestations of West Nile
virus infection but not for viral transmission. J Infect Dis. 2010;201:178–85.
35. Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation
between inbred laboratory mouse strains: points to consider in
phenotyping genetically immunomodified mice. Vet Pathol. 2012;49:32–43.
36. Phares TW, Kean RB, Mikheeva T, Hooper DC. Regional differences in blood-brain
barrier permeability changes and inflammation in the apathogenic clearance of
virus from the central nervous system. J Immunol. 2006;176:7666–75.
37. Magor BG, Magor KE. Evolution of effectors and receptors of innate
immunity. Dev Comp Immunol. 2001;25:651–82.
38. Shields DC. Molecular evolution of CXC chemokines and receptors. Trends
Immunol. 2003;24:355. author reply 356-357.
39. Quick ED, Leser JS, Clarke P, Tyler KL. Activation of intrinsic immune
responses and microglial phagocytosis in an ex vivo spinal cord slice culture
model of West Nile virus infection. J Virol. 2014;88:13005–14.
40. McCandless EE, Zhang B, Diamond MS, Klein RS. CXCR4 antagonism
increases T cell trafficking in the central nervous system and improves
survival from West Nile virus encephalitis. Proc Natl Acad Sci U S A. 2008;
105:11270–5.
41. Chu JJ, Ng ML. The mechanism of cell death during West Nile virus infection is
dependent on initial infectious dose. J Gen Virol. 2003;84:3305–14.
42. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like
receptor 3 mediates West Nile virus entry into the brain causing lethal
encephalitis. Nat Med. 2004;10:1366–73.

Page 8 of 8

Submit your next manuscript to BioMed Central
and we will help you at every step:
• We accept pre-submission inquiries
• Our selector tool helps you to find the most relevant journal
• We provide round the clock customer support
• Convenient online submission
• Thorough peer review
• Inclusion in PubMed and all major indexing services
• Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit

